Taking it to the Street: Thousands Strong, Fledgling South African Activist Group Sends Tremors Around the Globe
TAGline • 2000Thousands Strong, Fledgling South African Activist Group Sends Tremors Around the Globe September 2000 “Defiance Campaign” in the Offing Sunday afternoon as the Durban conference was just gearing up, some five thousand demonstrators singing, chanting and dancing marched from Durban City Hall to the stadium, calling on world pharmaceutical makers to cede the Third World…
Glaxo Guts Ghana’s Import of Generic Combivir and Prepares for Battle
TAGline • 2000December 2000 The arguments over affordable life-saving medicines for the developing world intensified late last month when it was revealed that Glaxo-Wellcome has blocked the importation of inexpensive generic knock-offs of its premier AIDS drug, Combivir, into Ghana (a small country in West Africa). The conflict is the latest skirmish in one of the most…
Being There: Durban Delegates Return Stateside, Fired Up and Ready to Jump Back Into the Fray
TAGline • 2000Durban Delegates Return Stateside, Fired Up and Ready to Jump Back Into the Fray September 2000 A Mouse Roars “The answer does not lie with donations or price cuts from drug companies but rather with the mass production of quality generics. This could result in the cost of a year’s antiretroviral treatment being cut to…
While You Were Sleeping: An African AIDS Aid Chronology
TAGline • 2000An African AIDS Aid Chronology September 2000 May 12, 1999 Bristol-Myers announces five-year donation of $100 million to fight AIDS in Botswana, Namibia, Lesotho, Swaziland, and South Africa. April 4, 2000 Pfizer offers free fluconazole to South Africans with AIDS suffering from cryptococcal meningitis. May 11 Five pharmaceutical companies (Boehringer Ingelheim, Bristol-Myers, Merck, Glaxo and…
Therapeutic Drug Monitoring in HIV Clinical Care
TAGline • 2000Ready for Prime Time?, 2000 Do We Need Another Lab Test in the Clinic? July 2000 No one could accuse the HIV pharmacologists of being attention hogs — but they were excited. It was the First International Workshop on Pharmacology in HIV Therapy, held on 30-31 March 2000 in Noordwijk, the Netherlands, a storm-swept town…
Research Rut: Beefed Up Federal AIDS Vaccine Program Found to Suffer from Lingering Shortcomings
TAGline • 2000Beefed Up Federal AIDS Vaccine Program Found to Suffer from Lingering Shortcomings April 2000 Tethered to the Past The first two decades of AIDS vaccine research have been characterized by a series of disappointments and setbacks. Indeed, while at the epidemic’s outset many predicted that it would be easier to develop a vaccine for HIV…
Statement on the Vaccines for the New Millennium Act of 2000
Statement / Press • 2000A Statement by Gregg Gonsalves, Policy Director of the Treatment Action Group, on the Vaccines for the New Millennium Act of 2000
Structured Treatment Interruptions (STIs) from the Seventh Retrovirus Conference, 2000
Publication • 2000February 2000 New York, NY by Mark Harrington At least 18 studies and speeches presented at the Seventh Retrovirus Conference included discussions related to treatment interruptions (TIs) and structured treatment interruptions (STIs) in various HIV infected populations — including primary HIV infection (three papers), chronic and virally suppressed (13 papers), and chronic and unsuppressed (two…
Data Drought: As Treatment Euphoria Ebbs, Stubborn Uncertainties Resurface But Are Unlikely to Be Resolved
TAGline • 1999As Treatment Euphoria Ebbs, Stubborn Uncertainties Resurface But Are Unlikely to Be Resolved ‘Unacceptable collective evasion’ Paul Joseph Corser 1961-1999 Rod Sorge 1969-1999 With the prolonged demise of HIV eradication hypotheses and the growing appreciation of the various unpleasant realities of lifelong HAART, the issue of the optimal time to initiate treatment with antiretroviral therapy…
Letter from Glasgow: Scottish Scribe Tells of Resistance Testing Success, Superinfection, Flaws in Dual Protease Regimens
TAGline • 1999Scottish Scribe Tells of Resistance Testing Success, Superinfection, Flaws in Dual Protease Regimens ‘Extensively reprised’ In contrast to U.K. Drug Therapy Congresses past, where physician attendance from the U.S. was rife but that of U.S. activists lackluster, this year’s late autumn retreat was graced not only with the presence but the participation of David Barr…